Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines

Amal Yussuf, Amanda B. Spurdle, Cristina Fortuno, D. Gareth Evans, Jeffrey N Weitzel, Jessica Mester, Jill Dolinsky, Joshua D. Schiffman, Judy E. Garber, Kara N. Maxwell, Kelly McGoldrick, Kim E Nichols, Maria Isabel Achatz, Paul A. James, Payal P Khincha, Renata Sandoval, Sharon A Savage, Tina Pesaran, MA, MS, CGC